A detailed history of Denkapparat Operations Gmb H transactions in Biogen Inc. stock. As of the latest transaction made, Denkapparat Operations Gmb H holds 1,620 shares of BIIB stock, worth $216,156. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,620
Holding current value
$216,156
% of portfolio
0.37%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$146.47 - $191.55 $237,281 - $310,311
1,620 New
1,620 $248 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $19.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Denkapparat Operations Gmb H Portfolio

Follow Denkapparat Operations Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denkapparat Operations Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Denkapparat Operations Gmb H with notifications on news.